Background：zanidatamab is a novel her2-targeted antibody that binds two distinct extracellular domains of her2, allowing for multiple mechanisms of action including enhanced binding, clustering, receptor internalization and downregulation
Alternative Names：ZW-25, ZW25, zanidatamab zovodotin,
